




OL"-f ./t^.lc 9 ,r;".i|*p sLoui 9 ,rS...il; e/.. ot1i.itc
:X,#l ,l,s4p *S;; o.r5-i:.ilc
*S-,r; s,a.ait;.5f.;i5J a?lc C"it-,lJ c/.e-
:gl9r
Jg)# &-.t" .#t{ .gL'iol-; ,.;.lt.^.ll -;1 i}#'[;.ll b 6t-o.1c 4{ JU d);l








c.q> l;.1, .5-r- c9>9.cul#.srl*t { yll-lr r+(f F .j,,V.S-- Ytt JlrJ 4S!-l c^lt a1: arJ-i.a
, drrh-l ! .tL,o { jU.*_r,1 .L a.JlL" 1l .i.ro..:-l ,U t;;U-l) Jrr--15 ou:olS .-,Lrr &F
..r,i! 
.* ;L"f ,t &-:a> rr AHNACC Y- \Y .r1Y "r-l5 r"Ll
or;r,19 rf ?... J F YYA1..r.i! .,.",.,.l&9F&irt &Jtt-.S,-45.-iofi arl-,J,.r5.il_r
(#), 
-.rL-c a LDL>190.,-g ,.srtqt re>9 s.Q- 1l 9 .r;.u -,1=:;l KERKARDS a,Jt-U^ r.t
AHNACC risk score crle .:u.:;1.! LDL>194 r 
-rL_" l ,,.1! .srQ a5 5clr-il.s.r-:;
.r,-l ,-:-- F,A.$Jri r!.--ii 7.Y,4 ;l ;;4 9 -# AHA SCOfe arrr 9J a19 .ri.u; CalCUlatOf
q rU I ou,; a*o-t-ia osfl ,r*-q Ui h j9,Yd-?. 9 A1-ff,fA-Y' e o;-f a- rc tor*;i
..r; oJ.:r.ir ta;l 
,o ;;L-l L ,rLrc
, -,iUD 17.9% ,LDL>I90 L'1.\,?,613 ctrL*r ! /.\f ,2,rlc;^ -^*.^a ,o a,Jl..l- ;,1 _,o : b drt-
.5tL* Li 7.\ \,4 . ,1.;1 .4a^z ro..r::;tc a,rfL-l l* ,-rL-r" d,t jtj 7.Y,A 6\L AHA SCOfe |1.\',?
a,"-;t-t! .-,L_r" 4i jU7.Y,4 6\\ AHA score |1.? t 
-L-" tr 7.8% ,LDL>I90 t.7.f ,Y ..,$
,_*1! .srL* .u:-:;lc AHNACC.TY .r-ti ..,,L1_l a#k-l ! .-rL_.,. t jU 45.9olr-!l ;p:*1..r::;lc
(.r"i u.ol9- # ,.srL.r ,t-r o.ru,-l Jo .ldr e F {)7.Y,A 6VL AHA score J9 Js;l$
r;c9, (.YY,A) cr- 
-Gl9 (7.AY,\ UL YA-2' ci- ol-f sr,, Gl clr-il ;,I..u:;lc
.i--lil irl o5 +L- .* ._i.-lit .i.iU-l l* ..rL_,o + jU. AHNACC 6y .r-15 ,,Ll ;.,6r.3 aa.::





Background: As high cholesterol levels is a significant risk factor contributing
to the occurrence of cardiac dr'seases, a guideline is required to initiate
treatmentwith statins. The purpose of this study is fo rnvestigate the
requirementfor statin treatment based on the AHNACC 2013 guideline in the
adult papulation of the City of Kerman
Materials and methods: ln the present research a number of 2259 cases out of
6000 cases who had entered the KERKARDS sfudy were selected and
examined for the presence of cardiac dr'seases, LDL>I90, and diabetes
mellitus.Ihose cases without cardiac diseases, diabetes mellitus, and
LDL>I9A entered AHNACC risk calculator and categorized into two groups of
AHA score lower or higher than 7.5%o, Ihese variables were compared with
one another in three age groups of 20-42, 45-59, and 60-75 years as well as
.gender distribution
Results.' ln the male cases, 14.6% with cardiac drsease, 2.6% with LDL>I90,
7.9% with diabetes mellitus, and 20.6%o with AHA score>7.S%o required statin
treatment. ln the female population, 11.8%io with cardiac disease, 4.77, with
LDL>190, 7.8% with diabetes mellitus, and 6%o with AHA score>7.5%o required
statin treatment. The majority of cases for whom statin treatment was required
based on AHNACC guideline did not have cardiac drsease while having AHA
.score>7.5To
Conclusion: Requirement for statin treatment rncreases with a higher
increase in case of the group with AHA score>7.S%o and without cardiac
dr'sease. This increase is mare prevalent among the age group of 60-75 years
and male cases
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